Liu Lin,Xu Weili.Research advances of integrated therapy of pediatric intestinal failure[J].Journal of Clinical Pediatric Surgery,2020,19(03):248-252.[doi:10.3969/j.issn.1671-6353.2020.03.011]
小儿肠功能衰竭综合治疗研究进展
- Title:
- Research advances of integrated therapy of pediatric intestinal failure
- Keywords:
- Pediatric Intestinal Failure; Integrated Treatment; Child
- 分类号:
- R726;R574.4
- 摘要:
- 小儿肠功能衰竭（pediatric intestinal failure，PIF）是一种罕见的、以肠道吸收功能不足为特点的疾病，病死率较高。随着对PIF研究的不断深入，营养治疗、药物治疗及手术治疗的综合治疗方案明显改善了PIF患儿的预后。本文就近年来研究PIF治疗的相关文献进行综述，为PIF的治疗提供参考依据。
- Abstract:
- Pediatric intestinal failure (PIF) is a rare condition with malabsorption and a high mortality.With deeper researches of PIF in recent years,integrated therapy strategies of nutritional supports,drug therapies and surgical interventions have improved the outcomes.This review aims to provide up-to-date perspectives for PIF treatment.
参考文献/References:
1 Duggan CP,Jaksic T.Pediatric intestinal failure[J].N Engl J Med,2017,377(7):666-675.DOI:10.1056/NEJMra1602650.
2 Wang H,Wang Y,Deng C,et al.Prediction of intestinal failure from necrotizing enterocolitis following surgery:A multicenter retrospective review[J].Medicine,2019,98(19):e15568.DOI:10.1097/MD.0000000000015568.
3 Fitzgibbons SC,Ching Y,Yu D,et al.Mortality of necrotizing enterocolitis expressed by birth weight categories[J].J Pediatr Surg,2009,44(6):1072-1076.DOI:10.1016/j.jpedsurg.2009.02.013.
4 Kaji T,Nakame K,Machigashira S,et al.Predictors of a successful outcome for infants with short bowel syndrome:a 30-year single-institution experience[J].Surgery Today,2017,47(11):1391-1396.DOI:10.1007/s00595-017-1534-6.
5 Squires RH,Duggan C,Teitelbaum DH,et al.Natural history of pediatric intestinal failure:initial report from the Pediatric Intestinal Failure Consortium[J].J Pediatr,2012,161(4):723-728.DOI:10.1016/j.jpeds.2012.03.062.
6 El Kasmi KC,Anderson AL,Devereaux MW,et al.Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease[J].Science Translational Medicine,2013,5(206):206ra137.DOI:10.1126/scitranslmed.3006898.
7 Gura KM,Calkins KL,Puder M.Use of fish oil intravenous lipid emulsions as monotherapy in the pediatric intestinal failure patient:beyond the package insert[J].Nutr Clin Pract,2019.DOI:10.1002/ncp.10413.
8 Nandivada P,Fell GL,Gura KM,et al.Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children[J].Am J Clin Nutr,2016,103(2):629S-634S.DOI:0.3945/ajcn.114.103986.
9 中国短肠综合征治疗协作组.中国短肠综合征诊疗共识(2016年版,南京)[J].中华胃肠外科杂志,2017,20(1):1-8.DOI:10.3760/cma.j.issn.1671-0274.2017.01.001.
Chinese Cooperative Treatment Group of Short Bowel Syndrome:Diagnostic & Therapeutic Consensus on Short Bowel Syndrome in China (Nanjing,2016 Edition)[J].Chinese Journal of Gastrointestinal Surgery,2017,20(1):1-8.DOI:10.3760/cma.j.issn.1671-0274.2017.01.001.
10 Cober MP,Killu G,Brattain A,et al.Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease[J].J Pediatr,2012,160(3):421-427.DOI:10.1016/j.jpeds.2011.08.047.
11 Rollins MD,Ward RM,Jackson WD,et al.Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease:a pilot study[J].J Pediatr Surg,2013,48(6):1348-1356.DOI:10.1016/j.jpedsurg.2013.03.040.
12 Anderson KT,Bartz-Kurycki MA,Martin R,et al.Tunneled central venous catheters in pediatric intestinal failure:a single-center experience[J].J Surg Res,2018,231:346-351.DOI:10.1016/j.jss.2018.05.081.
13 Sondheimer JM,Cadnapaphornchai M,Sontag M,et al.Predicting the duration of dependence on parenteral nutrition after neonatal intestinal resection[J].J Pediatr,1998,132(1):80-84.DOI:10.1016/s0022-3476(98)70489-5.
14 Vanderhoof JA,Young RJ.Enteral and parenteral nutrition in the care of patients with short-bowel syndrome[J].Best Practice & Research Clinical Gastroenterology,2003,17(6):997-1015.
15 Belza C,Wales JC,Courtney-Martin G,et al.An observational study of smoflipid vs intralipid on the evolution of intestinal failure-associated liver disease in infants with intestinal failure[J].J Parenter Enteral Nut,2019.DOI:10.1002/jpen.1692.
16 Nucci AM,Ellsworth K,Michalski A,et al.Survey of nutrition management practices in centers for pediatric intestinal rehabilitation[J].Nut Clin Pract,2018,33(4):528-538.DOI:10.1177/0884533617719670.
17 Yang CJ,Duro D,Zurakowski D,et al.High prevalence of multiple micronutrient deficiencies in children with intestinal failure:a longitudinal study[J].J Pediatr,2011,159(1):39-44.DOI:10.1016/j.jpeds.2010.12.049.
18 Ubesie AC,Heubi JE,Kocoshis SA,et al.Vitamin D deficiency and low bone mineral density in pediatric and young adult intestinal failure[J].J Pediatr Gastroenterol Nutr,2013,57(3):372.DOI:10.1097/MPG.0b013e31829c10eb.
19 Sieczkowska A,Landowski P,Gibas A,et al.Long-term proton pump inhibitor therapy leads to small bowel bacterial overgrowth as determined by breath hydrogen and methane excretion[J].J Breath Res,2018,12(3):036006.DOI:10.1088/1752-7163/aa9dcf.
20 Sentongo TA,Cohran V,Korff S,et al.Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome[J].J Pediatr Gastroenterol Nutr,2008,46(1):41-47.DOI:10.1097/01.mpg.0000304452.92175.f5.
21 Slim GM,Lansing M,Wizzard P,et al.Novel long-acting GLP-2 analogue,FE 203799 (Apraglutide),enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum[J].J Parent Enteral Nutr,2019.DOI:10.1002/jpen.1500.
22 Pevny S,Maasberg S,Rieger A,et al.Experience with teduglutide treatment for short bowel syndrome in clinical practice[J].Clin Nutr,2019,38(4):1745-1755.DOI:10.1016/j.clnu.2018.07.030.
23 O’Keefe SJD,Jeppesen PB,Gilroy R,et al.Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure[J].Clin Gastroenterol Hepatol,2013,11(7):815-823.DOI:10.1016/j.cgh.2012.12.029.
24 Jeppesen PB,Gabe SM,Seidner DL,et al.Factors associated with response to teduglutide in patients with short-bowel syndrome and intestinal failure[J].Gastroenterology,2018,154(4):874-885.DOI:10.1053/j.gastro.2017.11.023.
25 Lee JY,NamGung JM,Kim SC,et al.Serial transverse enteroplasty in children with short bowel syndrome[J].Transplantation,2017,101(6S2):S123.DOI:10.1097/01.tp.0000521469.57819.73.
26 Fitzgerald K,Muto M,Belza C,et al.The evolution of the serial transverse enteroplasty for pediatric short bowel syndrome at a single institution[J].J Pediatr Surg,2019,54(5):993-998.DOI:10.1016/j.jpedsurg.2019.01.051.
27 Frongia G,Kessler M,Weih S,et al.Comparison of LILT and STEP procedures in children with short bowel syndrome-a systematic review of the literature[J].J Pediatr Surg,2013,48(8):1794-1805.DOI:10.1016/j.jpedsurg.2013.05.018.
28 Wester T,Borg H,Naji H,et al.Serial transverse enteroplasty to facilitate enteral autonomy in selected children with short bowel syndrome[J].Br J Surg,2014,101(10):1329-1333.DOI:10.1002/bjs.9583.
29 Mercer DF,Hobson BD,Gerhardt BK,et al.Serial transverse enteroplasty allows children with short bowel to wean from parenteral nutrition[J].J Pediatr,2014,164(1):93-98.DOI:10.1016/j.jpeds.2013.08.039.
30 Kaufman SS,Atkinson JB,Bianchi A,et al.Indications for pediatric intestinal transplantation:a position paper of the American Society of Transplantation[J].Pediatr Transplant,2001,5(2):80-87.
31 Smith JM,Skeans MA,Horslen SP,et al.OPTN/SRTR 2015 Annual Data Report:Intestine[J].Am J Transplant,2017,17:252-285.DOI:10.1111/ajt.14127.
32 Sudan D.The current state of intestine transplantation:indications,techniques,outcomes and challenges[J].Am J Transplant,2014,14(9):1976-1984.DOI:10.1111/ajt.12812.
相似文献/References:
[1]李民驹. Ⅲ、Ⅳ期肾母细胞瘤综合治疗15年经验[J].临床小儿外科杂志,2011,10(04):243.
[J].Journal of Clinical Pediatric Surgery,2011,10(03):243.
[2]赵斯君 李赟 黄敏. 鼻腔纽扣电池异物38例[J].临床小儿外科杂志,2011,10(06):438.
[J].Journal of Clinical Pediatric Surgery,2011,10(03):438.
备注/Memo
收稿日期:2019-10-11。
基金项目:河北省重点研发计划健康医疗与生物医药专项项目（编号：18277747D）
通讯作者:徐伟立,Email:drxwl99@126.com